Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells. | Canada Hyperbarics Skip to main content
Clinical Study Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2018

Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells.

Wu X, Zhu Y, Huang W, Li J, Zhang B, Li Z, et al. — Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2018

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers coadministered Doxil with hyperbaric oxygen (HBO) therapy to assess the safety and efficacy of this combination treatment in solid tumors.

What They Found

They found that hyperbaric oxygen (HBO) therapy improved Doxil tumor penetration and sensitized tumor cells by overcoming hypoxia. This combination synergistically inhibited H22 tumor growth with a remarkable 91.5% inhibition rate. Importantly, the combined treatment showed no additional side effects or promotion of tumor metastasis.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

A limitation is that this was a preclinical study, and further human clinical trials are needed to confirm these findings.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 30128223
Year Published 2018
Journal Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.